Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages (Q73383699)
scientific article published on 01 January 2000
Language:
(P31) (Q13442814)
(P50) (Q56221878)
(P304) 2-7
(P433) 1
(P478) 60
(P577) Saturday, January 1, 2000
(P921) (Q18556536)
(Q412197)
(P1433) (Q326097)
(P1476) "Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages" (language: en)
(P2093) C J Bruns
H Shinohara
M T Harbison
D W Davis
G Nelkin
J J Killion
D J McConkey
Z Dong
other details
description scientific article published on 01 January 2000

External Links